On July 16, 2024, Apollomics Inc. (the “Company”) issued a press release announcing its receipt of a notice from The Nasdaq Stock Market LLC (“Nasdaq”), stating that although the Company had not regained compliance with the minimum bid price requirement by July 15, 2024, in accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company is eligible for an additional 180 calendar day period, or until January 13, 2025, to regain compliance with Nasdaq Listing Rule 5550(a)(2). To regain compliance, the closing bid price of the Company’s common stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days during this 180-day period. A copy of the press release is furnished hereto as Exhibit 99.1.
The press release set forth in Exhibit 99.1 is being furnished with the Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act.
Notwithstanding the foregoing, the information in the press release is incorporated by reference into the Company’s registration statements under the Securities Act, statements, including its registration statements on Form F-3 (File Nos. 333-278430, 333-278431 and 333-279549) and registration statement on Form S-8 (File No. 333-272559), and shall be a part thereof, to the extent not superseded by documents or reports subsequently filed or furnished.
EXHIBIT INDEX
| | |
Exhibit
Number | | Description of Exhibit |
| |
| 99.1 | | Press Release, dated July 16, 2024, entitled “Apollomics Granted 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement” |
